GLAXOSMITHKLINE PLC

GSK
Delayed Quote. Delayed  - 07/27 11:38:11 am
1399.2GBX -0.04%

Turn to zoom
Prev.1397.0000
Open1392.8000
High1401.8000
Low1383.2650
Volume3 926 470
Latest news
14h ago
14h ago
22h ago
1d ago
Chart GLAXOSMITHKLINE PLC
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralBullishNeutral
Resistance1 4441 4441 526
Spread/Res.-3,1%-3,1%-8,3%
Spread/Supp.0,32%5,2%18%
Support1 3951 3301 191
Financials
Sales 2021 33 019 M 45 858 M 45 858 M
Net income 2021 3 385 M 4 701 M 4 701 M
Net Debt 2021 21 463 M 29 809 M 29 809 M
P/E ratio 2021 20,4x
Yield 2021 5,71%
Capitalization 70 047 M 96 813 M 97 285 M
EV / Sales 2021 2,77x
EV / Sales 2022 2,59x
Nbr of Employees 94 066
Free-Float 92,2%
Company
GlaxoSmithKline PLC is a global healthcare company. The Company operates through two segments: Pharmaceuticals and Vaccines. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology...

>> Read more
Sector :
Other Pharmaceuticals
Calendar :
2021-07-28 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus OUTPERFORM
Number of Analysts 27
Last Close Price 1 399,80 GBX
Average target price 1 518,63 GBX
Spread / Average Target 8,49%